

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.43182789 |
| 2 | protein localization to endosome (GO:0036010) | 4.27262425 |
| 3 | neutrophil mediated immunity (GO:0002446) | 4.19258668 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.11107205 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.11107205 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 4.02660374 |
| 7 | response to fungus (GO:0009620) | 3.98968179 |
| 8 | defense response to fungus (GO:0050832) | 3.87689242 |
| 9 | pentose-phosphate shunt (GO:0006098) | 3.82991897 |
| 10 | leukocyte aggregation (GO:0070486) | 3.78866182 |
| 11 | negative regulation of phagocytosis (GO:0050765) | 3.74255629 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.67123288 |
| 13 | response to peptidoglycan (GO:0032494) | 3.67095990 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65370351 |
| 15 | amino sugar catabolic process (GO:0046348) | 3.62995159 |
| 16 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.62591389 |
| 17 | oligosaccharide catabolic process (GO:0009313) | 3.62444148 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.58583302 |
| 19 | glycolipid catabolic process (GO:0019377) | 3.57191873 |
| 20 | hemidesmosome assembly (GO:0031581) | 3.56166335 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.49823471 |
| 22 | skin morphogenesis (GO:0043589) | 3.44446490 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41321668 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41321668 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.41321668 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41321668 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.41321668 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41321668 |
| 29 | respiratory burst (GO:0045730) | 3.41171504 |
| 30 | neutrophil activation (GO:0042119) | 3.40258333 |
| 31 | NADPH regeneration (GO:0006740) | 3.30239436 |
| 32 | hypotonic response (GO:0006971) | 3.22962654 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21684013 |
| 34 | cellular extravasation (GO:0045123) | 3.20444511 |
| 35 | granulocyte activation (GO:0036230) | 3.19081929 |
| 36 | low-density lipoprotein particle clearance (GO:0034383) | 3.19022432 |
| 37 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11843582 |
| 38 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.09767871 |
| 39 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.09767871 |
| 40 | ceramide catabolic process (GO:0046514) | 3.07166066 |
| 41 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.06913360 |
| 42 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.06848984 |
| 43 | membrane raft organization (GO:0031579) | 3.06813165 |
| 44 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.06293520 |
| 45 | sequestering of metal ion (GO:0051238) | 3.04100837 |
| 46 | macrophage differentiation (GO:0030225) | 3.02922059 |
| 47 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02726103 |
| 48 | myeloid leukocyte mediated immunity (GO:0002444) | 3.02437299 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01457006 |
| 50 | pinocytosis (GO:0006907) | 3.00243001 |
| 51 | response to thyroid hormone (GO:0097066) | 2.99275677 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.97294923 |
| 53 | regulation of integrin activation (GO:0033623) | 2.96367178 |
| 54 | wound healing, spreading of epidermal cells (GO:0035313) | 2.96202621 |
| 55 | interferon-gamma secretion (GO:0072643) | 2.92804899 |
| 56 | T cell apoptotic process (GO:0070231) | 2.92645682 |
| 57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92215496 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 2.92153300 |
| 59 | stress fiber assembly (GO:0043149) | 2.91942382 |
| 60 | leukocyte mediated cytotoxicity (GO:0001909) | 2.91012355 |
| 61 | regulation of monocyte chemotaxis (GO:0090025) | 2.90874295 |
| 62 | glucose catabolic process (GO:0006007) | 2.89564403 |
| 63 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.88029195 |
| 64 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.87295226 |
| 65 | detection of external biotic stimulus (GO:0098581) | 2.86500964 |
| 66 | detection of other organism (GO:0098543) | 2.85890403 |
| 67 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85115161 |
| 68 | actin nucleation (GO:0045010) | 2.84957526 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 2.84784357 |
| 70 | apoptotic cell clearance (GO:0043277) | 2.83725522 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80952738 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 2.79965763 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 2.79251406 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78728006 |
| 75 | response to host immune response (GO:0052572) | 2.78728006 |
| 76 | leukotriene metabolic process (GO:0006691) | 2.72628392 |
| 77 | apoptotic process involved in morphogenesis (GO:0060561) | 2.72355882 |
| 78 | regulation of superoxide anion generation (GO:0032928) | 2.71560088 |
| 79 | positive regulation of extracellular matrix organization (GO:1903055) | 2.71469831 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 2.71024300 |
| 81 | response to host (GO:0075136) | 2.70162591 |
| 82 | response to host defenses (GO:0052200) | 2.70162591 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70162591 |
| 84 | reactive oxygen species biosynthetic process (GO:1903409) | 2.69998404 |
| 85 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.68632902 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68600808 |
| 87 | leukocyte cell-cell adhesion (GO:0007159) | 2.67096086 |
| 88 | response to progesterone (GO:0032570) | 2.66945806 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.66937646 |
| 90 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64740703 |
| 91 | hyaluronan catabolic process (GO:0030214) | 2.64547292 |
| 92 | NIK/NF-kappaB signaling (GO:0038061) | 2.64325160 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63076187 |
| 94 | regulation of mast cell activation (GO:0033003) | 2.62506778 |
| 95 | response to muramyl dipeptide (GO:0032495) | 2.61430205 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.61418870 |
| 97 | hepatocyte apoptotic process (GO:0097284) | 2.61297288 |
| 98 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.60560334 |
| 99 | regulation of mononuclear cell migration (GO:0071675) | 2.60271682 |
| 100 | surfactant homeostasis (GO:0043129) | 2.59507485 |
| 101 | positive regulation of receptor recycling (GO:0001921) | 2.58506299 |
| 102 | mannose metabolic process (GO:0006013) | 2.57739542 |
| 103 | regulation of early endosome to late endosome transport (GO:2000641) | 2.57713933 |
| 104 | endodermal cell differentiation (GO:0035987) | 2.57222983 |
| 105 | virion attachment to host cell (GO:0019062) | 2.56243010 |
| 106 | adhesion of symbiont to host cell (GO:0044650) | 2.56243010 |
| 107 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.56084473 |
| 108 | cell-substrate junction assembly (GO:0007044) | 2.54682451 |
| 109 | peptide catabolic process (GO:0043171) | 2.52700263 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.52220161 |
| 111 | lymphocyte apoptotic process (GO:0070227) | 2.50800846 |
| 112 | cell adhesion mediated by integrin (GO:0033627) | 2.50481320 |
| 113 | negative regulation of interleukin-8 production (GO:0032717) | 2.50409615 |
| 114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.49359233 |
| 115 | negative regulation of cell killing (GO:0031342) | 2.49359233 |
| 116 | membrane lipid catabolic process (GO:0046466) | 2.49195491 |
| 117 | wound healing, spreading of cells (GO:0044319) | 2.48409528 |
| 118 | COPI coating of Golgi vesicle (GO:0048205) | 2.48344508 |
| 119 | Golgi transport vesicle coating (GO:0048200) | 2.48344508 |
| 120 | response to laminar fluid shear stress (GO:0034616) | 2.46613517 |
| 121 | decidualization (GO:0046697) | 2.45778137 |
| 122 | sphingolipid catabolic process (GO:0030149) | 2.44568754 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.44493905 |
| 124 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44414038 |
| 125 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.44331815 |
| 126 | positive regulation of mast cell degranulation (GO:0043306) | 2.44331815 |
| 127 | regulation of regulated secretory pathway (GO:1903305) | 2.44100430 |
| 128 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.44056576 |
| 129 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.43865657 |
| 130 | response to magnesium ion (GO:0032026) | 2.43271026 |
| 131 | detection of biotic stimulus (GO:0009595) | 2.43159987 |
| 132 | positive regulation of interferon-alpha production (GO:0032727) | 2.42639191 |
| 133 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.42360139 |
| 134 | regulation of macrophage chemotaxis (GO:0010758) | 2.41772445 |
| 135 | cellular response to arsenic-containing substance (GO:0071243) | 2.41298600 |
| 136 | regulation of cholesterol storage (GO:0010885) | 2.41235878 |
| 137 | myeloid cell activation involved in immune response (GO:0002275) | 2.39994111 |
| 138 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.39865237 |
| 139 | positive regulation of leukocyte degranulation (GO:0043302) | 2.39685128 |
| 140 | protein localization to kinetochore (GO:0034501) | 2.39680309 |
| 141 | barbed-end actin filament capping (GO:0051016) | 2.39383350 |
| 142 | substrate-dependent cell migration (GO:0006929) | 2.39310560 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.36353123 |
| 144 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.36237586 |
| 145 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.35829198 |
| 146 | angiogenesis involved in wound healing (GO:0060055) | 2.35326391 |
| 147 | desmosome organization (GO:0002934) | 2.35232635 |
| 148 | regulation of phagocytosis (GO:0050764) | 2.34509752 |
| 149 | detection of bacterium (GO:0016045) | 2.33769119 |
| 150 | negative regulation of granulocyte differentiation (GO:0030853) | 2.33293685 |
| 151 | negative regulation of growth of symbiont in host (GO:0044130) | 2.33284251 |
| 152 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.33284251 |
| 153 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.33284251 |
| 154 | regulation of growth of symbiont in host (GO:0044126) | 2.33284251 |
| 155 | positive regulation of mast cell activation (GO:0033005) | 2.32584677 |
| 156 | heterochromatin organization (GO:0070828) | 2.32350041 |
| 157 | regulation of macrophage cytokine production (GO:0010935) | 2.32342188 |
| 158 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.31670019 |
| 159 | positive regulation of osteoblast proliferation (GO:0033690) | 2.31096414 |
| 160 | N-acetylneuraminate metabolic process (GO:0006054) | 2.31074973 |
| 161 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.30603463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.23678769 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.74846344 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10868686 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.10593768 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.77340268 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62563660 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.62216677 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49968802 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36120429 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30881637 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27243122 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.25870473 |
| 13 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24000778 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14899230 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12448291 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.11675683 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10651628 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.07272932 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92188057 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88296714 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87582831 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87158331 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87153830 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85599609 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81739639 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81220075 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79315612 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77153497 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76603599 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67683601 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66025817 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.65545437 |
| 33 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64751690 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60190157 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57102560 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.56952225 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52835760 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52549002 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.48866891 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47870485 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46868360 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44385310 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41014688 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40252946 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40069849 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40039427 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38853010 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37550261 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37338613 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37074692 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35314082 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34749649 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34319954 |
| 54 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.33570037 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33002784 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32517973 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30930999 |
| 58 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30220845 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30172313 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30150752 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29943853 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29057689 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28334820 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28216266 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28010682 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.27718143 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.27660718 |
| 68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27167020 |
| 69 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.26197126 |
| 70 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.25880398 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25115004 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23875391 |
| 73 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22000600 |
| 74 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21397810 |
| 75 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20412550 |
| 76 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20412550 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19999354 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19836299 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19651681 |
| 80 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.18197184 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17536349 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17434662 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16878830 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16144968 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15962860 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15573771 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14008481 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13424574 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13151000 |
| 90 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12073113 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11811013 |
| 92 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11731868 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10637656 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10049917 |
| 95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09045509 |
| 96 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08920339 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08284786 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08074756 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07601285 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07513214 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06500665 |
| 102 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.06114557 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05832841 |
| 104 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05800271 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05702620 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05375276 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04588621 |
| 108 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04072825 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03459022 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03136144 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02293235 |
| 112 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02079079 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01765484 |
| 114 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00799044 |
| 115 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00745586 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00701669 |
| 117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00491789 |
| 118 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99862545 |
| 119 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.99798549 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98937296 |
| 121 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98907916 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98163893 |
| 123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97768427 |
| 124 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96586028 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96549942 |
| 126 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.95970586 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95700340 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95510276 |
| 129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95339963 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94810693 |
| 131 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94691044 |
| 132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94308782 |
| 133 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93668438 |
| 134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93488212 |
| 135 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93230513 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91396724 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90497033 |
| 138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89515502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003566_abnormal_cell_adhesion | 2.79393282 |
| 2 | MP0003436_decreased_susceptibility_to | 2.77919943 |
| 3 | MP0003303_peritoneal_inflammation | 2.68252696 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.60926126 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.55801051 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.52810136 |
| 7 | MP0009278_abnormal_bone_marrow | 2.38485833 |
| 8 | MP0005451_abnormal_body_composition | 2.30363083 |
| 9 | MP0002419_abnormal_innate_immunity | 2.18014692 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.08298590 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 2.07681066 |
| 12 | MP0008260_abnormal_autophagy | 2.06140354 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.04502140 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.04502140 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.02019286 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.97920544 |
| 17 | MP0003693_abnormal_embryo_hatching | 1.96105904 |
| 18 | MP0000490_abnormal_crypts_of | 1.95937300 |
| 19 | MP0000604_amyloidosis | 1.95636342 |
| 20 | MP0005023_abnormal_wound_healing | 1.89902884 |
| 21 | MP0009785_altered_susceptibility_to | 1.89588095 |
| 22 | MP0000858_altered_metastatic_potential | 1.86130450 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.83838892 |
| 24 | MP0005025_abnormal_response_to | 1.74112259 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.73930321 |
| 26 | MP0010307_abnormal_tumor_latency | 1.73255856 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.71993926 |
| 28 | MP0004947_skin_inflammation | 1.68236065 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.67576533 |
| 30 | MP0000343_altered_response_to | 1.67396818 |
| 31 | MP0009840_abnormal_foam_cell | 1.66218423 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.62949355 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.61813479 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.58854907 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.58405179 |
| 36 | MP0003724_increased_susceptibility_to | 1.56574506 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.56421296 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.55142286 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.54752853 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.54149542 |
| 41 | MP0003448_altered_tumor_morphology | 1.53895679 |
| 42 | MP0001958_emphysema | 1.49007615 |
| 43 | MP0001542_abnormal_bone_strength | 1.48328952 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.46468153 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.46411403 |
| 46 | MP0002405_respiratory_system_inflammati | 1.46229704 |
| 47 | MP0002060_abnormal_skin_morphology | 1.45227159 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.44616389 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.43497351 |
| 50 | MP0001819_abnormal_immune_cell | 1.40800921 |
| 51 | MP0003329_amyloid_beta_deposits | 1.40089390 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.39548727 |
| 53 | MP0000685_abnormal_immune_system | 1.38056909 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.34264533 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.32962944 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.32817658 |
| 57 | MP0005387_immune_system_phenotype | 1.28726930 |
| 58 | MP0001790_abnormal_immune_system | 1.28726930 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.26687834 |
| 60 | MP0004272_abnormal_basement_membrane | 1.25647533 |
| 61 | MP0002723_abnormal_immune_serum | 1.25128405 |
| 62 | MP0001853_heart_inflammation | 1.24529314 |
| 63 | MP0001800_abnormal_humoral_immune | 1.22943552 |
| 64 | MP0006054_spinal_hemorrhage | 1.22936571 |
| 65 | MP0003091_abnormal_cell_migration | 1.20650748 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.19778994 |
| 67 | MP0001851_eye_inflammation | 1.18983025 |
| 68 | MP0004957_abnormal_blastocyst_morpholog | 1.17708091 |
| 69 | MP0005257_abnormal_intraocular_pressure | 1.17418328 |
| 70 | MP0003866_abnormal_defecation | 1.16911045 |
| 71 | MP0001873_stomach_inflammation | 1.16543426 |
| 72 | MP0001849_ear_inflammation | 1.13674241 |
| 73 | MP0002398_abnormal_bone_marrow | 1.13376688 |
| 74 | MP0009764_decreased_sensitivity_to | 1.08596278 |
| 75 | MP0000716_abnormal_immune_system | 1.07370807 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 1.05753909 |
| 77 | MP0001216_abnormal_epidermal_layer | 1.05142195 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.04895650 |
| 79 | MP0004883_abnormal_blood_vessel | 1.04730327 |
| 80 | MP0002722_abnormal_immune_system | 1.03761404 |
| 81 | MP0004510_myositis | 1.03556711 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.02785527 |
| 83 | MP0003075_altered_response_to | 1.01974096 |
| 84 | MP0002429_abnormal_blood_cell | 1.01872310 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.00617273 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.98329615 |
| 87 | MP0003077_abnormal_cell_cycle | 0.97090121 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.96687710 |
| 89 | MP0000579_abnormal_nail_morphology | 0.95876877 |
| 90 | MP0005166_decreased_susceptibility_to | 0.95002652 |
| 91 | MP0005165_increased_susceptibility_to | 0.94676037 |
| 92 | MP0003828_pulmonary_edema | 0.94588318 |
| 93 | MP0006082_CNS_inflammation | 0.93850249 |
| 94 | MP0003279_aneurysm | 0.93612122 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.92336463 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.92315162 |
| 97 | MP0005275_abnormal_skin_tensile | 0.92156819 |
| 98 | MP0000371_diluted_coat_color | 0.91279566 |
| 99 | MP0005501_abnormal_skin_physiology | 0.91259601 |
| 100 | MP0008004_abnormal_stomach_pH | 0.90698065 |
| 101 | MP0004858_abnormal_nervous_system | 0.89436152 |
| 102 | MP0005390_skeleton_phenotype | 0.87246134 |
| 103 | MP0003690_abnormal_glial_cell | 0.87113812 |
| 104 | MP0002796_impaired_skin_barrier | 0.86078260 |
| 105 | MP0002254_reproductive_system_inflammat | 0.85767921 |
| 106 | MP0005310_abnormal_salivary_gland | 0.85623119 |
| 107 | MP0005671_abnormal_response_to | 0.85258251 |
| 108 | MP0001243_abnormal_dermal_layer | 0.84314476 |
| 109 | MP0008469_abnormal_protein_level | 0.83926992 |
| 110 | MP0005621_abnormal_cell_physiology | 0.83871241 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.83356814 |
| 112 | MP0009053_abnormal_anal_canal | 0.80727850 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.80024141 |
| 114 | MP0009931_abnormal_skin_appearance | 0.79413835 |
| 115 | MP0003941_abnormal_skin_development | 0.79237079 |
| 116 | MP0005164_abnormal_response_to | 0.79158015 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.78112441 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.77947977 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.77015949 |
| 120 | MP0001663_abnormal_digestive_system | 0.76807960 |
| 121 | MP0000350_abnormal_cell_proliferation | 0.74849061 |
| 122 | MP0000920_abnormal_myelination | 0.74264942 |
| 123 | MP0000249_abnormal_blood_vessel | 0.74149866 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.73819533 |
| 125 | MP0005409_darkened_coat_color | 0.73432483 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.72560734 |
| 127 | MP0001191_abnormal_skin_condition | 0.72020920 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.70647157 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.70290824 |
| 130 | MP0003795_abnormal_bone_structure | 0.69422377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.20529236 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.11778793 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.59210423 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.76581963 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74524919 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.71962108 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 3.60125661 |
| 8 | Myositis (HP:0100614) | 3.52188856 |
| 9 | Interstitial pulmonary disease (HP:0006530) | 3.34307849 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13209047 |
| 11 | Thrombocytosis (HP:0001894) | 3.05578563 |
| 12 | Obstructive lung disease (HP:0006536) | 3.02373725 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02373725 |
| 14 | Pustule (HP:0200039) | 3.00972898 |
| 15 | Neurofibrillary tangles (HP:0002185) | 2.99924622 |
| 16 | Dysostosis multiplex (HP:0000943) | 2.93973484 |
| 17 | Myocardial infarction (HP:0001658) | 2.91841024 |
| 18 | Milia (HP:0001056) | 2.87664593 |
| 19 | Gingivitis (HP:0000230) | 2.85829557 |
| 20 | Cellulitis (HP:0100658) | 2.85756826 |
| 21 | Periodontitis (HP:0000704) | 2.85243829 |
| 22 | Atrophic scars (HP:0001075) | 2.84226265 |
| 23 | Thick nail (HP:0001805) | 2.81117193 |
| 24 | Orchitis (HP:0100796) | 2.78656210 |
| 25 | Recurrent fungal infections (HP:0002841) | 2.74066574 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73560090 |
| 27 | Mucopolysacchariduria (HP:0008155) | 2.71575191 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71575191 |
| 29 | Cervical subluxation (HP:0003308) | 2.70578812 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 2.68744263 |
| 31 | Cerebral aneurysm (HP:0004944) | 2.67478983 |
| 32 | Chronic otitis media (HP:0000389) | 2.57365728 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55155199 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55155199 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55155199 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.54571286 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.52752320 |
| 38 | Premature rupture of membranes (HP:0001788) | 2.49648752 |
| 39 | Protrusio acetabuli (HP:0003179) | 2.49411752 |
| 40 | Spondylolisthesis (HP:0003302) | 2.43795318 |
| 41 | Impaired platelet aggregation (HP:0003540) | 2.43452754 |
| 42 | Abnormal platelet function (HP:0011869) | 2.43452754 |
| 43 | Recurrent skin infections (HP:0001581) | 2.43389225 |
| 44 | Nasal polyposis (HP:0100582) | 2.41518081 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.40772973 |
| 46 | Hand muscle atrophy (HP:0009130) | 2.36586071 |
| 47 | Ulnar bowing (HP:0003031) | 2.36046805 |
| 48 | Peritonitis (HP:0002586) | 2.34110670 |
| 49 | Nuclear cataract (HP:0100018) | 2.31773276 |
| 50 | Natal tooth (HP:0000695) | 2.31335215 |
| 51 | Poikiloderma (HP:0001029) | 2.26758364 |
| 52 | Upper motor neuron abnormality (HP:0002127) | 2.26732016 |
| 53 | Short nail (HP:0001799) | 2.26601702 |
| 54 | Distal upper limb amyotrophy (HP:0007149) | 2.23701413 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.23701413 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.23564927 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.20617274 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.20535491 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.20535491 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.18917012 |
| 61 | Amyloidosis (HP:0011034) | 2.17378442 |
| 62 | Disinhibition (HP:0000734) | 2.16306032 |
| 63 | Petechiae (HP:0000967) | 2.15938519 |
| 64 | Loss of speech (HP:0002371) | 2.15246048 |
| 65 | Urticaria (HP:0001025) | 2.14671907 |
| 66 | Nail dystrophy (HP:0008404) | 2.13624461 |
| 67 | Cheilitis (HP:0100825) | 2.12586706 |
| 68 | Ureteral stenosis (HP:0000071) | 2.12162176 |
| 69 | Broad face (HP:0000283) | 2.12150032 |
| 70 | Radial bowing (HP:0002986) | 2.11925384 |
| 71 | Increased connective tissue (HP:0009025) | 2.11447353 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.10592709 |
| 73 | Agnosia (HP:0010524) | 2.08319627 |
| 74 | Purpura (HP:0000979) | 2.05984425 |
| 75 | Alopecia of scalp (HP:0002293) | 2.05931267 |
| 76 | Apathy (HP:0000741) | 2.05664155 |
| 77 | Malnutrition (HP:0004395) | 2.04106843 |
| 78 | Diminished motivation (HP:0000745) | 2.03944460 |
| 79 | Abnormal platelet volume (HP:0011876) | 2.03787144 |
| 80 | Entropion (HP:0000621) | 2.03567854 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.01991362 |
| 82 | Supranuclear gaze palsy (HP:0000605) | 2.00576076 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98466634 |
| 84 | Albinism (HP:0001022) | 1.97825111 |
| 85 | Skin ulcer (HP:0200042) | 1.97613467 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.96684047 |
| 87 | Pili torti (HP:0003777) | 1.96416290 |
| 88 | Abnormality of nail color (HP:0100643) | 1.96348132 |
| 89 | Epistaxis (HP:0000421) | 1.95985851 |
| 90 | Increased serum ferritin (HP:0003281) | 1.95946889 |
| 91 | Hematochezia (HP:0002573) | 1.95851430 |
| 92 | Ureteral obstruction (HP:0006000) | 1.95003435 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 1.94202826 |
| 94 | Vertebral compression fractures (HP:0002953) | 1.92161360 |
| 95 | Fragile skin (HP:0001030) | 1.92023478 |
| 96 | Osteomyelitis (HP:0002754) | 1.91029892 |
| 97 | Dilatation of the ascending aorta (HP:0005111) | 1.90500868 |
| 98 | Mitral stenosis (HP:0001718) | 1.90243720 |
| 99 | Selective tooth agenesis (HP:0001592) | 1.89968082 |
| 100 | Recurrent viral infections (HP:0004429) | 1.89452934 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 1.89137538 |
| 102 | Prolonged bleeding time (HP:0003010) | 1.88951837 |
| 103 | Increased mean platelet volume (HP:0011877) | 1.88160106 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 1.86764397 |
| 105 | Joint stiffness (HP:0001387) | 1.86385754 |
| 106 | IgM deficiency (HP:0002850) | 1.86205214 |
| 107 | Aortic aneurysm (HP:0004942) | 1.86189143 |
| 108 | Aortic dissection (HP:0002647) | 1.85506646 |
| 109 | Increased density of long bones (HP:0006392) | 1.85478890 |
| 110 | Plantar hyperkeratosis (HP:0007556) | 1.84375500 |
| 111 | Bone pain (HP:0002653) | 1.84082142 |
| 112 | Thin bony cortex (HP:0002753) | 1.83488753 |
| 113 | Onycholysis (HP:0001806) | 1.83432808 |
| 114 | Abnormal blistering of the skin (HP:0008066) | 1.82283601 |
| 115 | Vascular tortuosity (HP:0004948) | 1.82244611 |
| 116 | Prolonged neonatal jaundice (HP:0006579) | 1.82241664 |
| 117 | Increased IgE level (HP:0003212) | 1.81394416 |
| 118 | Bowing of the arm (HP:0006488) | 1.78946077 |
| 119 | Bowed forearm bones (HP:0003956) | 1.78946077 |
| 120 | Arterial tortuosity (HP:0005116) | 1.78862762 |
| 121 | Abnormality of the Achilles tendon (HP:0005109) | 1.77391112 |
| 122 | Wormian bones (HP:0002645) | 1.77261712 |
| 123 | Gastrointestinal dysmotility (HP:0002579) | 1.76703767 |
| 124 | Ankle contracture (HP:0006466) | 1.76686178 |
| 125 | Distal lower limb muscle weakness (HP:0009053) | 1.75922896 |
| 126 | Axonal loss (HP:0003447) | 1.75139498 |
| 127 | Shallow orbits (HP:0000586) | 1.74671896 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.74591494 |
| 129 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.74591494 |
| 130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.74591494 |
| 131 | Chest pain (HP:0100749) | 1.74504981 |
| 132 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72637583 |
| 133 | Premature loss of primary teeth (HP:0006323) | 1.72312996 |
| 134 | Inflammation of the large intestine (HP:0002037) | 1.71938063 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.70585852 |
| 136 | Menorrhagia (HP:0000132) | 1.70082587 |
| 137 | Fragile nails (HP:0001808) | 1.69177261 |
| 138 | Arterial thrombosis (HP:0004420) | 1.68956139 |
| 139 | Frequent falls (HP:0002359) | 1.68691411 |
| 140 | Spinal rigidity (HP:0003306) | 1.68351701 |
| 141 | Mutism (HP:0002300) | 1.68263913 |
| 142 | Polygenic inheritance (HP:0010982) | 1.67020239 |
| 143 | Elbow flexion contracture (HP:0002987) | 1.66926665 |
| 144 | Pathologic fracture (HP:0002756) | 1.66718599 |
| 145 | Genu recurvatum (HP:0002816) | 1.65238468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.48303757 |
| 2 | EPHA2 | 3.32268955 |
| 3 | TRIB3 | 3.16971318 |
| 4 | PIM2 | 2.60748228 |
| 5 | PRPF4B | 2.38219677 |
| 6 | PKN2 | 2.35999689 |
| 7 | TTN | 2.26025655 |
| 8 | STK10 | 2.24032543 |
| 9 | EEF2K | 2.14829229 |
| 10 | TAOK2 | 2.10258378 |
| 11 | PAK4 | 2.10203882 |
| 12 | IRAK4 | 1.99874612 |
| 13 | RIPK1 | 1.94360332 |
| 14 | TESK1 | 1.92037183 |
| 15 | EPHB1 | 1.90399301 |
| 16 | MAP4K1 | 1.84143869 |
| 17 | SIK1 | 1.82430252 |
| 18 | CDK12 | 1.78773590 |
| 19 | LRRK2 | 1.74684874 |
| 20 | KIT | 1.73703332 |
| 21 | TRPM7 | 1.69758857 |
| 22 | RPS6KB2 | 1.66849531 |
| 23 | TBK1 | 1.63382788 |
| 24 | PTK6 | 1.61271119 |
| 25 | NEK2 | 1.59429732 |
| 26 | BTK | 1.55808322 |
| 27 | GRK7 | 1.54937841 |
| 28 | PDGFRA | 1.53956509 |
| 29 | BLK | 1.53625141 |
| 30 | TESK2 | 1.47703555 |
| 31 | MAP3K3 | 1.44501006 |
| 32 | RIPK4 | 1.44311801 |
| 33 | TGFBR2 | 1.41331348 |
| 34 | MAP2K3 | 1.39279035 |
| 35 | MOS | 1.34341216 |
| 36 | IRAK3 | 1.32073840 |
| 37 | PRKD2 | 1.31749303 |
| 38 | ARAF | 1.29474986 |
| 39 | MAPKAPK3 | 1.29467690 |
| 40 | EPHB2 | 1.27704865 |
| 41 | PRKG2 | 1.25462985 |
| 42 | RPS6KA4 | 1.25332728 |
| 43 | PTK2 | 1.24850324 |
| 44 | MET | 1.24568542 |
| 45 | MAP3K11 | 1.24499097 |
| 46 | PIM1 | 1.22247329 |
| 47 | SCYL2 | 1.21799416 |
| 48 | CSK | 1.18456660 |
| 49 | CDC42BPA | 1.17461825 |
| 50 | SMG1 | 1.17071140 |
| 51 | MAP3K6 | 1.14871954 |
| 52 | FLT3 | 1.11262476 |
| 53 | MAP3K1 | 1.10757210 |
| 54 | KDR | 1.09612998 |
| 55 | LIMK1 | 1.09131744 |
| 56 | ZAP70 | 1.06074542 |
| 57 | CAMK1D | 1.05910205 |
| 58 | NEK9 | 1.04959240 |
| 59 | WEE1 | 1.03235019 |
| 60 | MAP3K8 | 1.02868831 |
| 61 | TEC | 1.01753520 |
| 62 | JAK3 | 1.01398044 |
| 63 | HCK | 1.01321871 |
| 64 | CDK6 | 0.98197961 |
| 65 | ICK | 0.98168017 |
| 66 | KSR2 | 0.96912656 |
| 67 | NME2 | 0.96138483 |
| 68 | TAOK1 | 0.96122501 |
| 69 | MATK | 0.92044184 |
| 70 | GRK6 | 0.91792615 |
| 71 | BMX | 0.87438027 |
| 72 | CDK7 | 0.87214672 |
| 73 | STK38 | 0.86347412 |
| 74 | TYK2 | 0.85812797 |
| 75 | MAP3K14 | 0.82800719 |
| 76 | PDPK1 | 0.82757425 |
| 77 | IKBKB | 0.78145572 |
| 78 | TAOK3 | 0.77868916 |
| 79 | NTRK1 | 0.75223002 |
| 80 | PAK2 | 0.75036026 |
| 81 | MARK3 | 0.73935156 |
| 82 | JAK1 | 0.72095144 |
| 83 | MAP3K2 | 0.70406329 |
| 84 | LATS2 | 0.69598405 |
| 85 | RPS6KA6 | 0.68232384 |
| 86 | FES | 0.67716237 |
| 87 | FGR | 0.67560052 |
| 88 | PDGFRB | 0.67061801 |
| 89 | PAK1 | 0.66006555 |
| 90 | RPS6KC1 | 0.65179282 |
| 91 | RPS6KL1 | 0.65179282 |
| 92 | MST1R | 0.63638105 |
| 93 | BRSK2 | 0.63003945 |
| 94 | AURKB | 0.62411148 |
| 95 | MAP3K5 | 0.60426335 |
| 96 | MAPKAPK2 | 0.60008649 |
| 97 | PTK2B | 0.59830803 |
| 98 | CSF1R | 0.59446114 |
| 99 | IRAK2 | 0.58347687 |
| 100 | MAP2K2 | 0.57679027 |
| 101 | MTOR | 0.57664029 |
| 102 | SIK3 | 0.57254515 |
| 103 | PIK3CG | 0.56417481 |
| 104 | MARK2 | 0.55887409 |
| 105 | STK4 | 0.55506216 |
| 106 | DAPK3 | 0.54302498 |
| 107 | CDK4 | 0.53760421 |
| 108 | ILK | 0.51618139 |
| 109 | CHUK | 0.51262646 |
| 110 | MYLK | 0.49360976 |
| 111 | TGFBR1 | 0.49143568 |
| 112 | MAP3K10 | 0.48731476 |
| 113 | MAP3K13 | 0.48658206 |
| 114 | STK24 | 0.48507539 |
| 115 | TTK | 0.48244822 |
| 116 | STK3 | 0.47833133 |
| 117 | ERBB4 | 0.47378809 |
| 118 | SIK2 | 0.47131046 |
| 119 | IKBKE | 0.46854377 |
| 120 | MST4 | 0.45672287 |
| 121 | PRKCI | 0.45411744 |
| 122 | ABL1 | 0.44554296 |
| 123 | SYK | 0.44086033 |
| 124 | LMTK2 | 0.43880496 |
| 125 | RPS6KA2 | 0.42638455 |
| 126 | DDR2 | 0.42496463 |
| 127 | ABL2 | 0.42490554 |
| 128 | RAF1 | 0.42451699 |
| 129 | ALK | 0.42128841 |
| 130 | LCK | 0.41848698 |
| 131 | ITK | 0.41061247 |
| 132 | MAPK7 | 0.39690104 |
| 133 | GSK3A | 0.36435054 |
| 134 | ROCK2 | 0.35583008 |
| 135 | DYRK1B | 0.34587601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47842268 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.47109301 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36054863 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23911902 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.03436314 |
| 6 | Shigellosis_Homo sapiens_hsa05131 | 1.96162467 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.88676986 |
| 8 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.76506815 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70445800 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68677505 |
| 11 | Apoptosis_Homo sapiens_hsa04210 | 1.65815339 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.58088806 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.58087646 |
| 14 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.57608111 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.55569083 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54940325 |
| 17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.54828670 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.53286937 |
| 19 | Bladder cancer_Homo sapiens_hsa05219 | 1.53262699 |
| 20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.51467787 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47917005 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.46917024 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44856242 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.43911993 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33343195 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32355224 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31306755 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30785703 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.30341552 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29307775 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.27949072 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.26307125 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24654065 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.24085969 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21715015 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20216205 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.14007288 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.13646249 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12416407 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.10907204 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10824387 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09706798 |
| 43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09424289 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08982252 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.07673875 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.07385269 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.06355142 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05338148 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05156720 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.04304939 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 1.04277247 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03586412 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01314454 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00679305 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97151742 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94339849 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.93866925 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91399364 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90667804 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90379290 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90299117 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89653534 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89461991 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89317242 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87436644 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87372611 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87186708 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85338195 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84268561 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84018843 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83053473 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.81970961 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80692847 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.80384115 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79318309 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.78957762 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76811075 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75655185 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75615904 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75583572 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75536923 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72490226 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71854343 |
| 84 | Ribosome_Homo sapiens_hsa03010 | 0.69538449 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68281044 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67581475 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65327021 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65074462 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64985446 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64542949 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63674947 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60948063 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60493173 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59521287 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58633179 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56500761 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56177985 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55661421 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.55232265 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54307110 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54154949 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53423604 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.52966940 |
| 104 | Mismatch repair_Homo sapiens_hsa03430 | 0.51214310 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50873662 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50852024 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50567422 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50563414 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.50492096 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50236662 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50100910 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49827721 |
| 113 | Homologous recombination_Homo sapiens_hsa03440 | 0.48080319 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47380523 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.46256506 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45371629 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44726606 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.44080856 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43907579 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43199582 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41580218 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41527613 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41503091 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39810869 |

